Genmont Biotech Overview

  • Founded
  • 2000
  • Status
  • Public
  • Employees
  • 147
  • Stock Symbol
  • 3164
Stock Symbol
  • Share Price
  • $0.86
  • (As of Friday Closing)

Genmont Biotech General Information


GenMont Biotech Incorporation manufactures and distributes functional lactobacillus (biotechnology medicines). Its products are used in the treatment of allergy, intestine, liver, hyperlipidaemia, arthritis, immunity and tooth health. Some of the products categories are L.paracasei 33 health food, Le Yikang Growth Milk Powder, GM-ADP probiotic series, GM-VGA Probiotics Care for Women, Digestive health care series and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Stock Exchange
Primary Office
  • No.8, Tainan Science-Based Industrl Prk Nan-Ke
  • 7th Road Shanhua District
  • Shanhua, 741
  • Taiwan
+886 06 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genmont Biotech Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.86 $0.87 $0.70 - $1.04 $74.3M 86.4M 59.6K $0.03

Genmont Biotech Financials Summary

In Thousands,
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 66,419 59,586 59,224 47,877
Revenue 14,068 11,048 11,205 13,476
EBITDA 4,181 3,278 3,006 5,004
Net Income 2,725 2,068 1,859 5,238
Total Assets 57,584 57,822 52,459 54,224
Total Debt 1,187 1,231 1,090 6
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genmont Biotech Patents

Genmont Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210213076-A1 Lactobacillus paracasei gmnl-346 for anti-oral cancer treatment and thereof Pending 14-Jan-2020 000000000
US-10639336-B1 Use of a probiotic composition for preventing stroke and ameliorating the severity of stroke Active 10-Jun-2019 0000000000
US-10638784-B2 Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof Active 12-Sep-2018 0000000000
US-20200077692-A1 Lactobacillus composition for inhibiting gastritis induced by gastric helicobacter pylori and use thereof Granted 12-Sep-2018 00000000
US-20200054694-A1 Topical composition, pharmaceutical composition containing inactivated culture and method of facilitating wound healing and scar reduction using the same Pending 14-Aug-2018 A61P17/02

Genmont Biotech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial